Interim Report for the period January – March 2021
New data continues to strengthen lecanemabEvents during the first quarter 2021 · BioArctic presented findings at the AD/PD conference suggesting that lecanemab could be developed into a disease modifying treatment for individuals with Down’s syndrome with dementia. · New preliminary results presented from the ongoing open-label extension of the Phase 2b study in early Alzheimer’s disease continued to support the effect of the drug candidate lecanemab on brain amyloid levels. Events after the period · Lecanemab Phase 2b study results in early Alzheimer’s disease published in
Technology leader in demanding ventilation, Halton Group, will begin providing their demand-controlled ventilation system, the Halton M.A.R.V.E.L, to commercial kitchens as a service which makes its benefits more conveniently available to more food service operators, such as restaurants, by minimizing the capital cost of the system.The Halton M.A.R.V.E.L system, connected via IoT, helps ensure continuous operation and predictable expenses in professional kitchens through predictive maintenance, and can significantly cut their energy costs and carbon footprint. Commercial kitchens use around
